Published in Gene Therapy Weekly, November 10th, 1997
In collaboration with researchers G. Stingl of Vienna and B. Brocker of Wurzburg, Austria, Walter Schmidt and colleagues from the Research Institute of Molecular Pathology, Vienna, Austria, presented the trial results at the 3rd European Conference on Gene Therapy of Cancer, held September 11-13, 1997, in Berlin, Germany, ("Cellular and Cell-Free Cancer Vaccines," Cancer Gene Therapy, September/October 1997;4(5)). Of the 43 patients recruited for the trial, 14 were evaluable.
"Patients tolerated the vaccine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.